The Distribution Move

Seed Health, the self-described number-one gut health supplements brand in the U.S. by combined Amazon and Target sales, is rolling out its DS-01® Daily Synbiotic to all Costco warehouse locations nationwide, the company announced Nov. 9. The product is offered in a Costco-exclusive 100-count jar — a 50-day supply priced at $74.99 — marking the microbiome science company's first entry into the club channel.

The Costco placement is a material step for a brand that has built its retail footprint sequentially across direct-to-consumer, Amazon, Target, Sprouts Farmers Market, and Erewhon. DS-01® holds the top-selling position in the digestive health probiotic subcategory at both Target and Amazon, according to SPINS data covering the 24 weeks ending January 2026. Club, by contrast, draws a broader, more value-oriented shopper and commands higher per-unit volume commitments — a threshold that signals commercial maturity for a supplements brand.

Growth Metrics in Context

Seed Health says it has grown revenue 13 times over the past five years while remaining profitable, though the company has not disclosed absolute revenue figures. That trajectory places it among the faster-scaling entrants in the functional supplements segment, a category that has drawn intensified investment from both legacy consumer-packaged-goods players and venture-backed challengers as consumer demand for gut-health products has outpaced the broader vitamins, minerals, and supplements market.

The Costco SKU is purpose-built for the channel: the 100-count jar does not appear in Seed's direct-to-consumer or existing retail assortment, following the standard club practice of differentiated pack sizes that limit direct price comparison. At $74.99 for 50 days, the implied per-day cost of roughly $1.50 is positioned below the brand's subscription pricing on its own site.

Product and Pipeline

DS-01® combines 24 probiotic strains with a prebiotic and is delivered via Seed's proprietary ViaCap® capsule-in-capsule technology, which the company says protects strains through the upper digestive tract for colonic release. The formulation has been evaluated in multiple human clinical trials, including what Seed describes as the largest randomized, placebo-controlled trial on a probiotic for bloating and gas in healthy adults, published in the journal Nutrients. In that study, 72% of DS-01® participants reported never or rarely feeling bloated by the study's end.

"Costco represents an important next step in that strategy, allowing us to bring the potential of microbiome science to even more people, with greater value and easier access than ever before," said Cathrin Bowtell, Chief Executive Officer of Seed Health. The company indicated it plans to expand across additional products and retail channels, targeting a mainstream consumer base for future gut-directed innovations.

For the broader functional food and beverage industry, the Costco debut underscores how premium health supplements — once confined to specialty retail and subscription e-commerce — are completing the journey into high-volume, price-sensitive mass channels. Operators and retail buyers in grocery and specialty food have tracked this pattern closely, as club placement typically accelerates brand awareness and can influence category resets across conventional supermarkets. Seed's move also reinforces the supply-chain investment required for clinical-stage brands to match club-channel volume demands without compromising formulation integrity.

Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.